Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

VCYT – Veracyte, Inc.

Veracyte, Inc.
VCYT
$27.38
Name : Veracyte, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $2,144,253,696.00
EPSttm : 0.42
finviz dynamic chart for VCYT
Veracyte, Inc.
$27.38
2.13%
$0.57

Float Short %

7.7

Margin Of Safety %

1

Put/Call OI Ratio

1.23

EPS Next Q Diff

0.23

EPS Last/This Y

0.98

EPS This/Next Y

0.04

Price

27.38

Target Price

41.9

Analyst Recom

1.5

Performance Q

-11.96

Relative Volume

3.6

Beta

2.08

Ticker: VCYT




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02VCYT26.740.280.321055
2025-06-03VCYT26.420.2927.001076
2025-06-04VCYT27.290.300.421084
2025-06-05VCYT27.060.290.501091
2025-06-06VCYT27.470.310.171096
2025-06-09VCYT27.860.315.331099
2025-06-10VCYT27.880.330.641115
2025-06-11VCYT27.920.340.071124
2025-06-12VCYT26.690.330.131150
2025-06-13VCYT26.430.304.331109
2025-06-16VCYT26.640.3110.101136
2025-06-17VCYT26.780.43999.991239
2025-06-18VCYT26.820.431.001239
2025-06-20VCYT26.370.410.001227
2025-06-23VCYT26.721.590.02494
2025-06-24VCYT26.881.230.07549
2025-06-25VCYT26.421.231.33552
2025-06-26VCYT26.81.240.00557
2025-06-27VCYT27.441.230.00559
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02VCYT26.74-0.971.01.28
2025-06-03VCYT26.50-0.969.51.28
2025-06-04VCYT27.29-0.973.91.28
2025-06-05VCYT26.98-0.969.21.30
2025-06-06VCYT27.47-0.972.61.30
2025-06-09VCYT27.850.072.11.30
2025-06-10VCYT27.880.070.61.30
2025-06-11VCYT27.930.070.71.30
2025-06-12VCYT26.690.065.51.30
2025-06-13VCYT26.430.069.41.30
2025-06-16VCYT26.640.071.31.30
2025-06-17VCYT26.750.071.01.30
2025-06-18VCYT26.820.070.71.30
2025-06-20VCYT26.390.068.71.30
2025-06-23VCYT26.690.071.81.30
2025-06-24VCYT26.880.071.21.30
2025-06-25VCYT26.440.068.61.30
2025-06-26VCYT26.780.072.01.30
2025-06-27VCYT27.380.072.91.30
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02VCYT-5.19-1.786.75
2025-06-03VCYT-5.19-1.786.75
2025-06-04VCYT-5.19-1.786.75
2025-06-05VCYT-4.46-1.786.75
2025-06-06VCYT-4.69-1.786.75
2025-06-09VCYT-2.80-1.756.75
2025-06-10VCYT-2.86-1.756.75
2025-06-11VCYT-2.86-1.757.08
2025-06-12VCYT-2.86-1.757.08
2025-06-13VCYT-2.86-1.757.08
2025-06-16VCYT-2.86-2.127.08
2025-06-18VCYT-3.17-2.127.08
2025-06-20VCYT-3.17-2.127.08
2025-06-23VCYT-3.17-2.127.08
2025-06-24VCYT-3.22-2.127.08
2025-06-25VCYT-3.22-2.127.08
2025-06-26VCYT-3.22-2.127.69
2025-06-27VCYT-2.91-2.127.70
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

0.09

Avg. EPS Est. Current Quarter

0.3

Avg. EPS Est. Next Quarter

0.32

Insider Transactions

-2.91

Institutional Transactions

-2.12

Beta

2.08

Average Sales Estimate Current Quarter

120

Average Sales Estimate Next Quarter

124

Fair Value

27.67

Quality Score

59

Growth Score

60

Sentiment Score

45

Actual DrawDown %

68.2

Max Drawdown 5-Year %

-81.2

Target Price

41.9

P/E

65.27

Forward P/E

37.14

PEG

1.43

P/S

4.63

P/B

1.79

P/Free Cash Flow

27.33

EPS

0.42

Average EPS Est. Cur. Y​

1.3

EPS Next Y. (Est.)

1.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.13

Relative Volume

3.6

Return on Equity vs Sector %

-21.1

Return on Equity vs Industry %

-7.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.11

EBIT Estimation

72.9
Veracyte, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 824
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
stock quote shares VCYT – Veracyte, Inc. Stock Price stock today
news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte, Inc. yahoo finance google finance
stock history VCYT – Veracyte, Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading